Myelodysplastic Syndromes:@0.659724:0.035749:0.914547:0.035749:0.914547:0.019993:0.659724:0.019993:0.017684:0.010314:0.012508:0.003848:0.012604:0.013181:0.010314:0.007466:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.009583:0.010314:0.011738:0.013181:0.005730:0.012604:0.018049:0.012508:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
95:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
or to completely alter the natural history of :@0.084848:0.096166:0.481107:0.096166:0.481107:0.080410:0.084848:0.080410:0.012604:0.005792:0.004599:0.006523:0.012604:0.004599:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.003848:0.010314:0.004618:0.013143:0.003848:0.006523:0.012508:0.005792:0.004603:0.006523:0.011738:0.012508:0.004601:0.011738:0.013143:0.006523:0.011699:0.005792:0.013143:0.003848:0.004609:0.011738:0.003848:0.007466:0.006523:0.012604:0.005792:0.010314:0.004603:0.012604:0.006042:0.005330
disease with a bone-marrow or stem-cell :@0.084848:0.112477:0.481084:0.112477:0.481084:0.096721:0.084848:0.096721:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007986:0.015990:0.003848:0.006523:0.011738:0.007986:0.013143:0.007986:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005703:0.012604:0.015990:0.007986:0.012604:0.005792:0.007974:0.007466:0.006523:0.012508:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330
transplantation.:@0.084848:0.128789:0.231071:0.128789:0.231071:0.113033:0.084848:0.113033:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
5:@0.231064:0.123181:0.237279:0.123181:0.237279:0.113996:0.231064:0.113996:0.006215
In lower-risk disease, treatment  options :@0.103030:0.145117:0.481090:0.145117:0.481090:0.129362:0.103030:0.129362:0.004349:0.011738:0.009044:0.003848:0.012604:0.015990:0.012508:0.005792:0.006388:0.005792:0.003848:0.007466:0.009660:0.009044:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.009044:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.003704:0.012604:0.013123:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
include growth factors (e.g., erythropoie-:@0.084846:0.161429:0.475771:0.161429:0.475771:0.145673:0.084846:0.145673:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007485:0.012950:0.005709:0.012604:0.015990:0.006523:0.011738:0.007485:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.007476:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.007470:0.012508:0.005792:0.010314:0.006523:0.011738:0.005703:0.012604:0.013123:0.012604:0.003848:0.012508:0.006388
tin, granulocyte colony-stimulating factors :@0.084846:0.177741:0.481093:0.177741:0.481093:0.161985:0.084846:0.161985:0.006523:0.003848:0.011738:0.005330:0.005436:0.012950:0.005792:0.013143:0.011738:0.011699:0.003848:0.012604:0.012450:0.010314:0.006523:0.012496:0.005446:0.012450:0.012604:0.003848:0.012604:0.011738:0.010314:0.006388:0.007466:0.006523:0.003848:0.018049:0.011699:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.005436:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330
[G-CSF]),  immune-suppressive  treatments :@0.524246:0.096156:0.920490:0.096156:0.920490:0.080400:0.524246:0.080400:0.006754:0.016779:0.006388:0.015644:0.009583:0.009333:0.006754:0.007100:0.005330:0.005330:0.004012:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.006388:0.007466:0.011699:0.013123:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.010660:0.012519:0.005330:0.004008:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330
and  immunomodulatory  agents  (e.g.,  le-:@0.524246:0.112468:0.915160:0.112468:0.915160:0.096712:0.524246:0.096712:0.013143:0.011738:0.013181:0.005330:0.003046:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.018049:0.012604:0.013181:0.011699:0.003848:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.003038:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.003044:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.005330:0.003036:0.003848:0.012508:0.006388
nalidomide).   In  patients with  higher-risk :@0.524246:0.128779:0.920496:0.128800:0.920496:0.113044:0.524246:0.113024:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.007100:0.005330:0.006219:0.005330:0.006052:0.004349:0.011738:0.005330:0.006050:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.011392:0.015990:0.003848:0.006523:0.011738:0.005330:0.006050:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792:0.006388:0.005792:0.003848:0.007466:0.009660:0.374951
5:@0.642628:0.123181:0.648843:0.123181:0.648843:0.113996:0.642628:0.113996:0.006215
disease, demethylating agents (e.g., aza-:@0.524250:0.145112:0.915160:0.145112:0.915160:0.129356:0.524250:0.129356:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.006215:0.013181:0.012508:0.018049:0.012508:0.006523:0.011738:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.006215:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.006215:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.006215:0.013143:0.008178:0.013143:0.006388
cytidine,  decitabine),  intensive chemo-:@0.524250:0.161423:0.915160:0.161423:0.915160:0.145667:0.524250:0.145667:0.012450:0.010314:0.006523:0.003848:0.013181:0.003848:0.011738:0.012508:0.005330:0.005330:0.008436:0.013181:0.012508:0.012450:0.003848:0.006523:0.013143:0.013123:0.003848:0.011738:0.012508:0.007100:0.005330:0.005330:0.008438:0.003848:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.010660:0.012508:0.013778:0.012450:0.011738:0.012508:0.018049:0.012586:0.006388
therapy  and stem-cell transplantation :@0.524250:0.177735:0.920500:0.177735:0.920500:0.161979:0.524250:0.161979:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013075:0.013143:0.011738:0.013181:0.018415:0.007466:0.006523:0.012508:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.018415:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
Table 1. Revised international prognostic scoring system (IPSS-R) in myelodysplastic syndrome:@0.084850:0.208651:0.903037:0.208651:0.903037:0.192618:0.084850:0.192618:0.007505:0.012123:0.012123:0.004041:0.011738:0.004811:0.010198:0.004811:0.004811:0.010583:0.011738:0.010198:0.004041:0.007889:0.011738:0.012123:0.004811:0.004041:0.010968:0.005195:0.011738:0.005580:0.010968:0.012123:0.005195:0.004041:0.011738:0.010968:0.012123:0.004041:0.004811:0.012123:0.005580:0.011738:0.012123:0.010968:0.011738:0.007889:0.005195:0.004041:0.011738:0.004811:0.007889:0.011738:0.011738:0.005580:0.004041:0.010968:0.012123:0.004811:0.007889:0.010583:0.007889:0.005195:0.011738:0.017511:0.004811:0.006735:0.004811:0.010198:0.009429:0.009429:0.007505:0.010583:0.006735:0.004811:0.004041:0.010968:0.004811:0.017511:0.010583:0.011738:0.004041:0.011738:0.012123:0.010583:0.007889:0.012123:0.004041:0.012123:0.007889:0.005195:0.004041:0.011738:0.004811:0.007889:0.010583:0.010968:0.012123:0.005580:0.011738:0.017511:0.012315
Prognostic variable:@0.094474:0.241501:0.269965:0.241501:0.269965:0.225468:0.094474:0.225468:0.010583:0.005965:0.012123:0.012508:0.011353:0.012123:0.008274:0.005580:0.004426:0.012123:0.005195:0.010583:0.012508:0.005965:0.004426:0.012508:0.012508:0.004426:0.012315
Score:@0.321861:0.241501:0.374201:0.241501:0.374201:0.225468:0.321861:0.225468:0.009814:0.012123:0.012123:0.005965:0.012315
0:@0.321861:0.266002:0.332637:0.266002:0.332637:0.249968:0.321861:0.249968:0.010776
0.5:@0.407836:0.266002:0.434776:0.266002:0.434776:0.249968:0.407836:0.249968:0.010776:0.005388:0.010776
1.0:@0.493811:0.266002:0.520751:0.266002:0.520751:0.249968:0.493811:0.249968:0.010776:0.005388:0.010776
1.5:@0.603031:0.266002:0.629971:0.266002:0.629971:0.249968:0.603031:0.249968:0.010776:0.005388:0.010776
2.0:@0.657584:0.266002:0.684523:0.266002:0.684523:0.249968:0.657584:0.249968:0.010776:0.005388:0.010776
3.0:@0.800016:0.266002:0.826955:0.266002:0.826955:0.249968:0.800016:0.249968:0.010776:0.005388:0.010776
4.0:@0.860629:0.266002:0.887569:0.266002:0.887569:0.249968:0.860629:0.249968:0.010776:0.005388:0.010776
Cytogenetics*:@0.094493:0.290502:0.227747:0.290502:0.227747:0.274746:0.094493:0.274746:0.015644:0.010314:0.006523:0.012604:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.007466:0.008178
Very :@0.321881:0.290502:0.367391:0.290502:0.367391:0.274746:0.321881:0.274746:0.011567:0.012508:0.005792:0.010314:0.005330
good:@0.321881:0.306668:0.373219:0.306668:0.373219:0.290912:0.321881:0.290912:0.012950:0.012604:0.012604:0.013181
 :@0.407856:0.290502:0.413186:0.290502:0.413186:0.274746:0.407856:0.274746:0.005330
Good:@0.493831:0.290502:0.548999:0.290502:0.548999:0.274746:0.493831:0.274746:0.016779:0.012604:0.012604:0.013181
 :@0.603051:0.290502:0.608381:0.290502:0.608381:0.274746:0.603051:0.274746:0.005330
Intermediate:@0.657603:0.290502:0.778797:0.290502:0.778797:0.274746:0.657603:0.274746:0.004349:0.011738:0.006523:0.012508:0.006317:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508
Poor Very :@0.800035:0.290502:0.906159:0.290502:0.906159:0.274746:0.800035:0.274746:0.011392:0.012604:0.012604:0.005792:0.018223:0.011567:0.012508:0.005792:0.010314:0.005330
poor:@0.860649:0.306668:0.904771:0.306668:0.904771:0.290912:0.860649:0.290912:0.013123:0.012604:0.012604:0.005792
Bone-marrow blast :@0.094512:0.331169:0.274844:0.331169:0.274844:0.315413:0.094512:0.315413:0.011045:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005707:0.012604:0.015990:0.005330:0.013123:0.003848:0.013143:0.007466:0.006523:0.005330
(percent):@0.094512:0.347335:0.183222:0.347335:0.183222:0.331579:0.094512:0.331579:0.007100:0.013123:0.012508:0.005659:0.012450:0.012508:0.011738:0.006523:0.007100
≤2 :@0.321900:0.331169:0.348454:0.331169:0.348454:0.315413:0.321900:0.315413:0.010564:0.010660:0.005330
 :@0.407875:0.331169:0.413205:0.331169:0.413205:0.315413:0.407875:0.315413:0.005330
>2 to <5 :@0.493850:0.331169:0.573610:0.331169:0.573610:0.315413:0.493850:0.315413:0.011661:0.010660:0.005330:0.006523:0.012604:0.005330:0.011661:0.010660:0.005330
 :@0.603070:0.331169:0.608400:0.331169:0.608400:0.315413:0.603070:0.315413:0.005330
5 to 10 :@0.657622:0.331169:0.724720:0.331169:0.724720:0.315413:0.657622:0.315413:0.010660:0.005330:0.006523:0.012604:0.005330:0.010660:0.010660:0.005330
>10 :@0.800054:0.331169:0.838366:0.331169:0.838366:0.315413:0.800054:0.315413:0.011661:0.010660:0.010660:0.005330
 :@0.860668:0.331169:0.865998:0.331169:0.865998:0.315413:0.860668:0.315413:0.005330
Haemoglobin (g/dL):@0.094532:0.371848:0.285051:0.371848:0.285051:0.356092:0.094532:0.356092:0.013143:0.013143:0.012508:0.018049:0.012604:0.012950:0.003848:0.012604:0.013123:0.003848:0.011738:0.005330:0.007100:0.012950:0.008409:0.013181:0.008890:0.007100
≥10:@0.321919:0.371848:0.353804:0.371848:0.353804:0.356092:0.321919:0.356092:0.010564:0.010660:0.010660
 :@0.407894:0.371848:0.413224:0.371848:0.413224:0.356092:0.407894:0.356092:0.005330
8 to <10:@0.493869:0.371848:0.567298:0.371848:0.567298:0.356092:0.493869:0.356092:0.010660:0.005330:0.006523:0.012604:0.005330:0.011661:0.010660:0.010660
<8:@0.603089:0.371848:0.625410:0.371848:0.625410:0.356092:0.603089:0.356092:0.011661:0.010660
 :@0.657641:0.371848:0.662971:0.371848:0.662971:0.356092:0.657641:0.356092:0.005330
 :@0.800074:0.371848:0.805404:0.371848:0.805404:0.356092:0.800074:0.356092:0.005330
 :@0.860687:0.371848:0.866017:0.371848:0.866017:0.356092:0.860687:0.356092:0.005330
Platelets (cells/microL):@0.094551:0.396349:0.301936:0.396349:0.301936:0.380593:0.094551:0.380593:0.011392:0.003848:0.013143:0.006523:0.012508:0.003848:0.012508:0.006523:0.007466:0.005330:0.007100:0.012450:0.012508:0.003848:0.003848:0.007466:0.008409:0.018049:0.003848:0.012450:0.005725:0.012604:0.008890:0.007100
≥100:@0.321938:0.396349:0.364483:0.396349:0.364483:0.380593:0.321938:0.380593:0.010564:0.010660:0.010660:0.010660
50 to :@0.407913:0.396349:0.459021:0.396349:0.459021:0.380593:0.407913:0.380593:0.010660:0.010660:0.005330:0.006523:0.012604:0.005330
100:@0.407913:0.412515:0.439894:0.412515:0.439894:0.396759:0.407913:0.396759:0.010660:0.010660:0.010660
<50:@0.493888:0.396349:0.526870:0.396349:0.526870:0.380593:0.493888:0.380593:0.011661:0.010660:0.010660
 :@0.603108:0.396349:0.608438:0.396349:0.608438:0.380593:0.603108:0.380593:0.005330
 :@0.657661:0.396349:0.662991:0.396349:0.662991:0.380593:0.657661:0.380593:0.005330
 :@0.800093:0.396349:0.805423:0.396349:0.805423:0.380593:0.800093:0.380593:0.005330
 :@0.860706:0.396349:0.866037:0.396349:0.866037:0.380593:0.860706:0.380593:0.005330
Absolute neutrophil :@0.094570:0.437028:0.280567:0.437028:0.280567:0.421272:0.094570:0.421272:0.014239:0.013123:0.007466:0.012604:0.003848:0.011699:0.006523:0.012508:0.005330:0.011738:0.012508:0.011699:0.006523:0.005696:0.012604:0.013123:0.011738:0.003848:0.003848:0.005330
count (cells/microL):@0.094570:0.453194:0.279199:0.453194:0.279199:0.437439:0.094570:0.437439:0.012450:0.012604:0.011699:0.011738:0.006523:0.005330:0.007100:0.012450:0.012508:0.003848:0.003848:0.007466:0.008409:0.018049:0.003848:0.012450:0.005713:0.012604:0.008890:0.007100
≥0.8:@0.321958:0.437028:0.359172:0.437028:0.359172:0.421272:0.321958:0.421272:0.010564:0.010660:0.005330:0.010660
<0.8:@0.407933:0.437028:0.446244:0.437028:0.446244:0.421272:0.407933:0.421272:0.011661:0.010660:0.005330:0.010660
 :@0.493908:0.437028:0.499238:0.437028:0.499238:0.421272:0.493908:0.421272:0.005330
 :@0.603128:0.437028:0.608458:0.437028:0.608458:0.421272:0.603128:0.421272:0.005330
 :@0.657680:0.437028:0.663010:0.437028:0.663010:0.421272:0.657680:0.421272:0.005330
 :@0.800112:0.437028:0.805442:0.437028:0.805442:0.421272:0.800112:0.421272:0.005330
 :@0.860726:0.437028:0.866056:0.437028:0.866056:0.421272:0.860726:0.421272:0.005330
This scoring system was applied to an initial group of 7012 patients with primary MDS by :@0.094589:0.477708:0.905903:0.477708:0.905903:0.461952:0.094589:0.461952:0.008197:0.011738:0.003848:0.007466:0.005330:0.007466:0.012450:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330:0.015990:0.013143:0.007466:0.005330:0.013143:0.013123:0.013123:0.003848:0.003848:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330:0.013143:0.011738:0.005330:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.005330:0.012950:0.005711:0.012604:0.011699:0.013123:0.005330:0.012604:0.006042:0.005330:0.010660:0.010660:0.010660:0.010660:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.005330:0.017684:0.014316:0.009583:0.005330:0.013123:0.010314:0.005330
the French-American-British classification who had at least two months of stable blood :@0.094589:0.493874:0.900888:0.493874:0.900888:0.478118:0.094589:0.478118:0.006523:0.011738:0.012508:0.005330:0.009333:0.005700:0.012508:0.011738:0.012450:0.011738:0.006388:0.014239:0.018049:0.012508:0.005792:0.003848:0.012450:0.013143:0.011738:0.006388:0.011045:0.005792:0.003848:0.006523:0.003848:0.007466:0.011738:0.005330:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.015990:0.011738:0.012604:0.005330:0.011738:0.013143:0.013181:0.005330:0.013143:0.006523:0.005330:0.003848:0.012508:0.013143:0.007466:0.006523:0.005330:0.006523:0.015990:0.012604:0.005330:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330:0.012604:0.006042:0.005330:0.007466:0.006523:0.013143:0.013123:0.003848:0.012508:0.005330:0.013123:0.003848:0.012604:0.012604:0.013181:0.005330
counts, ≤30 percent bone-marrow blasts and ≤19 percent peripheral blood blasts, and :@0.094589:0.510040:0.902143:0.510040:0.902143:0.494284:0.094589:0.494284:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005330:0.005330:0.010564:0.010660:0.010660:0.005330:0.013123:0.012508:0.005646:0.012450:0.012508:0.011738:0.006523:0.005330:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005694:0.012604:0.015990:0.005330:0.013123:0.003848:0.013143:0.007466:0.006523:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.010564:0.010660:0.010660:0.005330:0.013123:0.012508:0.005659:0.012450:0.012508:0.011738:0.006523:0.005330:0.013123:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.013123:0.003848:0.012604:0.012604:0.013181:0.005330:0.013123:0.003848:0.013143:0.007466:0.006523:0.007466:0.005330:0.005330:0.013143:0.011738:0.013181:0.005330
who were observed until progression to AML transformation or death (did not receive :@0.094589:0.526206:0.891411:0.526206:0.891411:0.510450:0.094589:0.510450:0.015990:0.011738:0.012604:0.005330:0.015990:0.012508:0.005703:0.012508:0.005330:0.012604:0.013123:0.007466:0.012508:0.005792:0.010660:0.012508:0.013181:0.005330:0.011699:0.011738:0.006523:0.003848:0.003848:0.005330:0.013123:0.005703:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.006523:0.012604:0.005330:0.014239:0.017684:0.008890:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.012604:0.006296:0.018049:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012604:0.005792:0.005330:0.013181:0.012508:0.013143:0.006523:0.011738:0.005330:0.007100:0.013181:0.003848:0.013181:0.005330:0.011738:0.012604:0.006523:0.005330:0.005680:0.012508:0.012450:0.012508:0.003848:0.010660:0.012508:0.005330
disease-modifying agents for MDS). Patients could be stratified into five groups with the :@0.094589:0.542372:0.906272:0.542372:0.906272:0.526616:0.094589:0.526616:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.006388:0.018049:0.012604:0.013181:0.003848:0.006042:0.010314:0.003848:0.011738:0.012950:0.005330:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.006042:0.012604:0.005792:0.005330:0.017684:0.014316:0.009583:0.007100:0.005330:0.005330:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.012450:0.012604:0.011699:0.003848:0.013181:0.005330:0.013123:0.012508:0.005330:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.003848:0.011738:0.006523:0.012604:0.005330:0.004686:0.004686:0.010660:0.012508:0.005330:0.012950:0.005657:0.012604:0.011699:0.013123:0.007466:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330
following estimated overall survival and progression to AML.:@0.094589:0.558538:0.647706:0.558538:0.647706:0.542782:0.094589:0.542782:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.013181:0.005330:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.005330:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.013143:0.011738:0.013181:0.005330:0.013123:0.005719:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.006523:0.012604:0.005330:0.014239:0.017684:0.008890:0.005330
Risk group:@0.094474:0.605847:0.188954:0.605847:0.188954:0.589814:0.094474:0.589814:0.010968:0.004426:0.008274:0.010968:0.005195:0.012508:0.005965:0.012123:0.011353:0.012700
IPSS-R score:@0.301599:0.605847:0.411858:0.605847:0.411858:0.589814:0.301599:0.589814:0.005195:0.010583:0.009814:0.009814:0.007889:0.010968:0.005195:0.008274:0.012123:0.012123:0.005965:0.012315
Median overall :@0.508724:0.605847:0.651690:0.605847:0.651690:0.589814:0.508724:0.589814:0.017126:0.012123:0.012508:0.004426:0.012508:0.011353:0.005195:0.012123:0.010583:0.012123:0.005965:0.012508:0.004426:0.004612:0.005388
survival (years):@0.508724:0.622013:0.646307:0.622013:0.646307:0.605980:0.508724:0.605980:0.008274:0.011353:0.005965:0.010583:0.004426:0.010583:0.012508:0.004426:0.005195:0.007120:0.010968:0.012123:0.012508:0.005965:0.008274:0.007312
Median time to :@0.715850:0.605847:0.859594:0.605847:0.859594:0.589814:0.715850:0.589814:0.017126:0.012123:0.012508:0.004426:0.012508:0.011353:0.005195:0.005580:0.004426:0.017895:0.012123:0.005195:0.005580:0.012319:0.005388
25 percent AML :@0.715850:0.622013:0.864207:0.622013:0.864207:0.605980:0.715850:0.605980:0.010583:0.010583:0.005195:0.012508:0.012123:0.005965:0.012123:0.012123:0.011353:0.005580:0.005195:0.014047:0.017126:0.008465:0.005388
evolution (years):@0.715850:0.638179:0.869404:0.638179:0.869404:0.622146:0.715850:0.622146:0.012123:0.010583:0.012123:0.004426:0.011353:0.005580:0.004426:0.012123:0.011353:0.005195:0.007120:0.010968:0.012123:0.012508:0.005965:0.008274:0.007312
Very low:@0.094493:0.662680:0.172446:0.662680:0.172446:0.646924:0.094493:0.646924:0.011567:0.012508:0.005792:0.010314:0.005330:0.003848:0.012604:0.015990
≤1.5:@0.301618:0.662680:0.338833:0.662680:0.338833:0.646924:0.301618:0.646924:0.010564:0.010660:0.005330:0.010660
8.8:@0.508744:0.662680:0.535394:0.662680:0.535394:0.646924:0.508744:0.646924:0.010660:0.005330:0.010660
>14.5:@0.715869:0.662680:0.764841:0.662680:0.764841:0.646924:0.715869:0.646924:0.011661:0.010660:0.010660:0.005330:0.010660
Low:@0.094512:0.687180:0.131996:0.687180:0.131996:0.671424:0.094512:0.671424:0.008890:0.012604:0.015990
>1.5 to 3.0:@0.301638:0.687180:0.396387:0.687180:0.396387:0.671424:0.301638:0.671424:0.011661:0.010660:0.005330:0.010660:0.005330:0.006523:0.012604:0.005330:0.010660:0.005330:0.010660
5.3:@0.508763:0.687180:0.535414:0.687180:0.535414:0.671424:0.508763:0.671424:0.010660:0.005330:0.010660
10.8:@0.715888:0.687180:0.753199:0.687180:0.753199:0.671424:0.715888:0.671424:0.010660:0.010660:0.005330:0.010660
Intermediate:@0.094532:0.711681:0.215726:0.711681:0.215726:0.695925:0.094532:0.695925:0.004349:0.011738:0.006523:0.012508:0.006317:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508
>3 to 4.5:@0.301657:0.711681:0.380416:0.711681:0.380416:0.695925:0.301657:0.695925:0.011661:0.010660:0.005330:0.006523:0.012604:0.005330:0.010660:0.005330:0.010660
3.0:@0.508782:0.711681:0.535433:0.711681:0.535433:0.695925:0.508782:0.695925:0.010660:0.005330:0.010660
3.2:@0.715907:0.711681:0.742558:0.711681:0.742558:0.695925:0.715907:0.695925:0.010660:0.005330:0.010660
High:@0.094551:0.736181:0.136230:0.736181:0.136230:0.720425:0.094551:0.720425:0.013143:0.003848:0.012950:0.011738
>4.5 to 6:@0.301676:0.736181:0.380435:0.736181:0.380435:0.720425:0.301676:0.720425:0.011661:0.010660:0.005330:0.010660:0.005330:0.006523:0.012604:0.005330:0.010660
1.6:@0.508801:0.736181:0.535452:0.736181:0.535452:0.720425:0.508801:0.720425:0.010660:0.005330:0.010660
1.4:@0.715927:0.736181:0.742577:0.736181:0.742577:0.720425:0.715927:0.720425:0.010660:0.005330:0.010660
Very high:@0.094570:0.760681:0.180355:0.760681:0.180355:0.744926:0.094570:0.744926:0.011567:0.012508:0.005792:0.010314:0.005330:0.011738:0.003848:0.012950:0.011738
>6:@0.301695:0.760681:0.324016:0.760681:0.324016:0.744926:0.301695:0.744926:0.011661:0.010660
0.8:@0.508821:0.760681:0.535471:0.760681:0.535471:0.744926:0.508821:0.744926:0.010660:0.005330:0.010660
0.7:@0.715946:0.760681:0.742596:0.760681:0.742596:0.744926:0.715946:0.744926:0.010660:0.005330:0.010660
The prognostic value of the IPSS-R was validated in an external cohort of 200 patients :@0.094589:0.785182:0.890218:0.785182:0.890218:0.769426:0.094589:0.769426:0.008197:0.011738:0.012508:0.005330:0.013123:0.005703:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005330:0.010660:0.013143:0.003848:0.011699:0.012508:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.004349:0.011392:0.009583:0.009583:0.006388:0.011680:0.005330:0.015990:0.013143:0.007466:0.005330:0.010660:0.013143:0.003848:0.003848:0.013181:0.013143:0.006523:0.012508:0.013181:0.005330:0.003848:0.011738:0.005330:0.013143:0.011738:0.005330:0.012508:0.009236:0.006523:0.012508:0.006163:0.011738:0.013143:0.003848:0.005330:0.012450:0.012604:0.011738:0.012604:0.005792:0.006523:0.005330:0.012604:0.006042:0.005330:0.010660:0.010660:0.010660:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with MDS:@0.094589:0.801348:0.179602:0.801348:0.179602:0.785592:0.094589:0.785592:0.015990:0.003848:0.006523:0.011738:0.005330:0.017684:0.014316:0.009583
AML: acute myeloid leukaemia; MDS: myelodysplastic syndrome. *Cytogenetic definitions: :@0.084849:0.830124:0.835933:0.830124:0.835933:0.816119:0.084849:0.816119:0.012657:0.015719:0.007902:0.004738:0.004738:0.011682:0.011067:0.010399:0.005798:0.011118:0.004738:0.016044:0.009168:0.011118:0.003421:0.011203:0.003421:0.011716:0.004738:0.003421:0.011118:0.010399:0.008586:0.011682:0.011118:0.016044:0.003421:0.011682:0.004738:0.004738:0.015719:0.012726:0.008518:0.004738:0.004738:0.016044:0.009168:0.011118:0.003421:0.011203:0.011716:0.009168:0.006636:0.011665:0.003421:0.011682:0.006636:0.005798:0.003421:0.011067:0.004738:0.006636:0.009168:0.010434:0.011716:0.005078:0.011203:0.016044:0.011118:0.004738:0.004738:0.007269:0.013906:0.009168:0.005798:0.011203:0.011511:0.011118:0.010434:0.011118:0.005798:0.003421:0.011067:0.004738:0.011716:0.011118:0.004165:0.004165:0.010434:0.003421:0.005798:0.003421:0.011203:0.010434:0.006636:0.004738:0.004738
Very good: -Y, del(11q).Good: Normal, del(5q), del(12p), del(20q), double including del(5q). :@0.084849:0.844235:0.848604:0.844235:0.848604:0.830230:0.084849:0.830230:0.010281:0.011118:0.005148:0.009168:0.004738:0.011511:0.011203:0.011203:0.011716:0.004738:0.004738:0.005679:0.008441:0.004738:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.009476:0.011665:0.006312:0.004738:0.014915:0.011203:0.011203:0.011716:0.004738:0.004738:0.012657:0.011203:0.005612:0.016044:0.011682:0.003421:0.004738:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.009476:0.011665:0.006312:0.004738:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.009476:0.011665:0.006312:0.004738:0.004738:0.011716:0.011203:0.010399:0.011665:0.003421:0.011118:0.004738:0.003421:0.010434:0.011067:0.003421:0.010399:0.011716:0.003421:0.010434:0.011511:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738
Intermediate: del(7q), +8, +19, i(17q), any other single, double not including del(5q) or -7/del(7q), :@0.084849:0.858346:0.891239:0.858346:0.891239:0.844341:0.084849:0.844341:0.003866:0.010434:0.005798:0.011118:0.005615:0.016044:0.011118:0.011716:0.003421:0.011682:0.005798:0.011118:0.004738:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738:0.010365:0.009476:0.004738:0.004738:0.010365:0.009476:0.009476:0.004738:0.004738:0.003421:0.006312:0.009476:0.009476:0.011665:0.006312:0.004738:0.004738:0.011682:0.010434:0.009168:0.004738:0.011203:0.005798:0.010434:0.011118:0.005148:0.004738:0.006636:0.003421:0.010434:0.011511:0.003421:0.011118:0.004738:0.004738:0.011716:0.011203:0.010399:0.011665:0.003421:0.011118:0.004738:0.010434:0.011203:0.005798:0.004738:0.003421:0.010434:0.011067:0.003421:0.010399:0.011716:0.003421:0.010434:0.011511:0.004738:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.011203:0.005148:0.004738:0.005679:0.009476:0.007475:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738
or independent clones. Poor: -7, inv(3)/t(3q)/del(3q), double including -7/del(7q), complex: 3 :@0.084849:0.872457:0.857589:0.872457:0.857589:0.858452:0.084849:0.858452:0.011203:0.005148:0.004738:0.003421:0.010434:0.011716:0.011118:0.011665:0.011118:0.010434:0.011716:0.011118:0.010434:0.005798:0.004738:0.011067:0.003421:0.011203:0.010434:0.011118:0.006636:0.004738:0.004738:0.010126:0.011203:0.011203:0.005148:0.004738:0.004738:0.005679:0.009476:0.004738:0.004738:0.003421:0.010434:0.009476:0.006312:0.009476:0.006312:0.007475:0.005798:0.006312:0.009476:0.011665:0.006312:0.007475:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738:0.011716:0.011203:0.010399:0.011665:0.003421:0.011118:0.004738:0.003421:0.010434:0.011067:0.003421:0.010399:0.011716:0.003421:0.010434:0.011511:0.004738:0.005679:0.009476:0.007475:0.011716:0.011118:0.003421:0.006312:0.009476:0.011665:0.006312:0.004738:0.004738:0.011067:0.011203:0.016044:0.011665:0.003421:0.011118:0.008210:0.004738:0.004738:0.009476:0.004738
abnormalities. Very poor: Complex: >3 abnormalities.:@0.084849:0.886569:0.522104:0.886569:0.522104:0.872563:0.084849:0.872563:0.011682:0.011665:0.010434:0.011203:0.005619:0.016044:0.011682:0.003421:0.003421:0.005798:0.003421:0.011118:0.006636:0.004738:0.004738:0.010287:0.011118:0.005148:0.009168:0.004738:0.011665:0.011203:0.011203:0.005148:0.004738:0.004738:0.013906:0.011203:0.016044:0.011665:0.003421:0.011118:0.008210:0.004738:0.004738:0.010365:0.009476:0.004738:0.011682:0.011665:0.010434:0.011203:0.005595:0.016044:0.011682:0.003421:0.003421:0.005798:0.003421:0.011118:0.006636:0.004738
Source: This research was originally published in Blood. Greenberg PL, Tuechler H, Schanz J,:@0.084849:0.907808:0.740613:0.907808:0.740613:0.895553:0.084849:0.895553:0.007453:0.009803:0.009100:0.004505:0.009683:0.009728:0.004146:0.004146:0.006376:0.009129:0.002993:0.005807:0.004146:0.004505:0.009728:0.005807:0.009728:0.010222:0.004505:0.009683:0.009129:0.004146:0.012437:0.010222:0.005807:0.004146:0.009803:0.004505:0.002993:0.010072:0.002993:0.009129:0.010222:0.002993:0.002993:0.008022:0.004146:0.010207:0.009100:0.010207:0.002993:0.002993:0.005807:0.009129:0.009728:0.010252:0.004146:0.002993:0.009129:0.004146:0.008591:0.002993:0.009803:0.009803:0.010252:0.004146:0.004146:0.013051:0.004505:0.009728:0.009728:0.009129:0.010207:0.009728:0.004505:0.010072:0.004146:0.008860:0.006914:0.004146:0.004146:0.006376:0.009100:0.009728:0.009683:0.009129:0.002993:0.009728:0.004505:0.004146:0.010222:0.004146:0.004146:0.007453:0.009683:0.009129:0.010222:0.009129:0.006361:0.004146:0.007214:0.004146
 et al.:@0.740553:0.907808:0.781007:0.907808:0.781007:0.895553:0.740553:0.895553:0.004146:0.009728:0.005074:0.004146:0.010222:0.002993:0.004146
 Revised :@0.781007:0.907808:0.845182:0.907808:0.845182:0.895553:0.781007:0.895553:0.004146:0.009085:0.009728:0.008291:0.002993:0.005807:0.009728:0.010252:0.004146
International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012. Copyright © 2012 the :@0.084849:0.921040:0.900902:0.921040:0.900902:0.908785:0.084849:0.908785:0.003382:0.009129:0.005074:0.009728:0.004505:0.009129:0.010222:0.005074:0.002993:0.009803:0.009129:0.010222:0.002993:0.004146:0.008860:0.004505:0.009803:0.010072:0.009129:0.009803:0.005807:0.005074:0.002993:0.009683:0.004146:0.007453:0.009683:0.009803:0.004505:0.002993:0.009129:0.010072:0.004146:0.007453:0.008022:0.005807:0.005074:0.009728:0.014038:0.004146:0.005523:0.003382:0.008860:0.007453:0.007453:0.004969:0.009085:0.005523:0.004146:0.004699:0.009803:0.004505:0.004146:0.014038:0.008022:0.009728:0.002993:0.009803:0.010252:0.008022:0.005807:0.010207:0.002993:0.010222:0.005807:0.005074:0.002993:0.009683:0.004146:0.005807:0.008022:0.009129:0.010252:0.004505:0.009803:0.014038:0.009728:0.005807:0.004146:0.004146:0.008591:0.002993:0.009803:0.009803:0.010252:0.004146:0.008291:0.008291:0.008291:0.008291:0.004146:0.004146:0.012168:0.009803:0.010207:0.008022:0.004505:0.002993:0.010072:0.009129:0.005074:0.004146:0.011180:0.004146:0.008291:0.008291:0.008291:0.008291:0.004146:0.005074:0.009129:0.009728:0.004146
American Society of Hematology. Graphic 85832 Version 2.0:@0.084849:0.934272:0.521072:0.934272:0.521072:0.922017:0.084849:0.922017:0.011075:0.014038:0.009728:0.004505:0.002993:0.009683:0.010222:0.009129:0.004146:0.007453:0.009803:0.009683:0.002993:0.009728:0.005074:0.008022:0.004146:0.009803:0.004699:0.004146:0.010222:0.009728:0.014038:0.010222:0.005074:0.009803:0.002993:0.009803:0.010072:0.008022:0.004146:0.004146:0.013051:0.004505:0.010222:0.010207:0.009129:0.002993:0.009683:0.004146:0.008291:0.008291:0.008291:0.008291:0.008291:0.004146:0.010506:0.009728:0.004505:0.005807:0.002993:0.009803:0.009129:0.004146:0.008291:0.004146:0.008291